Reassessing the Role for Lamivudine in Chronic Hepatitis B Infection: A Four-Year Cohort Analysis
The data supporting the use of antiviral agents other than lamivudine in the management of patients with hepatitis B virus (HBV) infection are based on highly selected clinical trial populations that may not be representative of typical HBV-infected populations encountered in many clinics. Despite i...
Saved in:
Main Authors: | Tahir Shaikh, Curtis Cooper |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2012-01-01
|
Series: | Canadian Journal of Gastroenterology |
Online Access: | http://dx.doi.org/10.1155/2012/936259 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Predictive Factors of Lamivudine Treatment Success in a Hepatitis B Virus-Infected Pediatric Cohort: A 10-Year Study
by: Yasmine Yousef, et al.
Published: (2012-01-01) -
Serum Beta2-Microglobulin Levels in Hepatitis B e Antigen-Negative Chronic Hepatitits B Patients under Long-Term Lamivudine Monotherapy: Relationship with Virological Breakthrough
by: Ioannis S Elefsiniotis, et al.
Published: (2004-01-01) -
Reassessment of Visually Impaired Patients after Surgery. A Four-case Report
by: Armando Rafael Milanés Armengol, et al.
Published: (2015-09-01) -
Principles in the Management of Chronic Hepatitis B Viral Infection
by: Gerald Y Minuk
Published: (1999-01-01) -
Hepatitis B and Hepatitis C Viral Infections in Patients with Chronic Lymphocytic Leukemia
by: Gerald Y Minuk, et al.
Published: (2014-01-01)